anti thymocyt globulin wikipedia free encyclopedia anti thymocyt globulin from wikipedia free encyclopedia redirect from thymoglobulin jump navig search anti thymocyt globulin systemat iupac name identifi ca number atc code l04aa03 l04aa04 pubchem chemic data formula mol mass pharmacokinet data bioavail metabol half life excret therapeut consider pregnanc cat legal statu rout anti thymocyt globulin atg infus hors rabbit deriv antibodi against human t cell which us prevent treatment acut reject organ transplant therapi aplast anemia content 1 us 2 complic altern 3 histori 4 refer edit us two antithymocyt globulin atg agent licens clinic us unit state thymoglobulin rabbit atg ratg genzym atgam equin atg eatg pfizer thymoglobulin atgam current licens us treatment renal allograft reject atgam addition licens us treatment aplast anemia both drug us off label applic especi immunosuppress induct agent befor dure kidnei transplant ratg product made freseniu market outsid unit state atg administr veri substanti reduc immun compet patient normal immun system through combin action some explicitli understood some more hypothet ratg particular effect larg reduct through cell lysi number circul t lymphocyt henc prevent least delai cellular reject transplant organ howev medic opinion remain divid when benefit profound reduct t cell outweigh concomit increas risk infect malign unit state frequent given time transplant prevent graft versu host diseas 1 although mani european center prefer reserv it us treatment steroid resist acut reject european centr gener serv more homogen popul reject tend less problem edit complic altern atg us can induc cytokin releas syndrom ha been thought increas risk post transplant lymphoprolif disord ptld howev associ mai appli when lower dose regimen us some evid suggest induc immunosuppress ratg organ transplant mai creat condit patient' immun system favor develop immunolog toler exact basi develop remain larg specul temporari deplet t cell popul time transplant also risk delai acut reject which mai miss caus sever damag graft anti il 2r receptor antibodi basiliximab daclizumab increasingli be us place atg induct therapi do caus cytokin releas syndrom theoret improv develop toler cytokin releas syndrom associ atg administr frequent caus high grade fever over 39oc chill possibli rigor dure administr which reason steroid normal methylprednisolon diphenhydramin acetaminophen usual co administ advers reaction can often control slow infus rate edit histori first report immun anim on speci guinea pig against immun cell anoth speci mous lymphocyt metchnikoff 1899 he report inject cell recov from mous lymph node guinea pig wait immun result accumul anti mous antibodi guinea pig blood when he subsequ collect serum from guinea pig inject normal mice he observ mark deplet number circul mous lymphocyt edit refer antithymocyt globulin entri public domain nci dictionari cancer term immunologi articl stub you can help wikipedia expand v d e immunomodul immunosuppress drug immunosuppress l04 intracellular signal initi antimetabolit purin synthesi inhibitor azathioprin mycophenol acid pyrimidin synthesi inhibitor leflunomid teriflunomid antifol methotrex macrolid other il 2 inhibitor fkbp cyclophilin calcineurin tacrolimu ciclosporin pimecrolimu abetimu gusperimu tnf inhibitor thalidomid lenalidomid intracellular signal recept il 1 receptor antagonist anakinra mtor sirolimu deforolimu everolimu temsirolimu zotarolimu extracellular antibodi monoclon serum target noncellular complement compon 5 eculizumab tnf infliximab adalimumab certolizumab pegol afelimomab golimumab interleukin 5 mepolizumab immunoglobulin e omalizumab bayx nerelimomab interferon faralimomab il 6 elsilimomab il 12 il 13 ustekinumab cellular target cd3 muromonab cd3 otelixizumab teplizumab visilizumab cd4 clenoliximab keliximab zanolimumab cd11a efalizumab cd18 erlizumab cd20 afutuzumab ocrelizumab pascolizumab cd23 lumiliximab cd40 teneliximab toralizumab cd62l l selectin aselizumab cd80 galiximab cd147 basigin gavilimomab ziralimumab cd154 ruplizumab bly belimumab ctla 4 ipilimumab tremelimumab cat bertilimumab lerdelimumab metelimumab integrin natalizumab interleukin 6 receptor tocilizumab lfa 1 odulimomab il 2 receptor cd25 basiliximab daclizumab inolimomab t lymphocyt zolimomab aritox unsort atlizumab atorolimumab cedelizumab dorlimomab aritox dorlixizumab fontolizumab gantenerumab gomiliximab lebrilizumab maslimomab morolimumab pexelizumab reslizumab rovelizumab siplizumab talizumab telimomab aritox vapaliximab vepalimomab polyclon anti thymocyt globulin anti lymphocyt globulin cept fusion protein ctla 4 abatacept belatacept aflibercept alefacept rilonacept tnf inhibitor etanercept retriev from http en.wikipedia.org wiki anti thymocyte_globulin categori immunosuppress agent polyclon antibodi immunologi stub hidden categori drug page need structur draw view articl discuss edit page histori person tool log creat account navig main page content featur content current event random articl search interact about wikipedia commun portal recent chang contact wikipedia donat wikipedia help toolbox what link here relat chang upload file special page printabl version perman link cite page page last modifi 10 march 2009 01 39 all text avail under term gnu free document licens see copyright detail wikipedia regist trademark wikimedia foundat inc u. regist 501 c 3 tax deduct nonprofit chariti privaci polici about wikipedia disclaim